🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

518 results for “Cho” Clear

  1. Levobupivacaína Normon 5 mg/ml solución inyectable y para perfusión EFG, Inibsacain 5 mg/ml + 0,005 mg/ml solución inyectable en cartucho

    The George Institute

    Hip fracture

    approved small molecule active

    1 trial
  2. Livmarli 9.5 mg/mL oral solution

    Lacuna Pharma Pty Ltd

    Progressive Familial Intrahepatic Cholestasis, Alagille syndrome

    approved small molecule active

    1 trial
  3. MUCODRILL 600 mg SANS SUCRE, comprimé effervescent édulcoré au sucralose, FOLINORAL 25 mg, gélule, VITAMINE B12 GERDA 250 microgrammes, comprimé sécable, Omacor 1000 mg capsules molles

    Pari Pharma GmbH

    Ultra High Risk of psychosis and first episode psychosis

    approved small molecule active

    1 trial
  4. Minoxidil lotion 1%

    Hospital Authority, Hong Kong

    Eyebrow Hypotrichosis

    approved small molecule completed

    1 trial
  5. Minoxidil lotion 2%

    Hospital Authority, Hong Kong

    Hypotrichosis of Eyebrows

    approved small molecule completed

    1 trial
  6. Mobile Surgical Vehicle Echocardiography-guided ASD closure Group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    ASD - Atrial Septal Defect

    approved other active

    1 trial
  7. Pimavanserin

    Acadia Pharmaceuticals B.V.

    Parkinson Disease Psychosis

    approved small molecule completed

    1 trial
  8. Placebo of rosuvastatin 10mg (tablet) as produced by Apotheek A15, Rosuvastatin tablet 10mg Apotheek A15

    Disc Medicine

    Statin-intolerance, High cardiovascular risk (previous cardiovascular disease or familial hypercholesterolemia)

    approved small molecule active

    1 trial
  9. Praluent

    Regeneron UK Limited

    Heterozygous Familial Hypercholesterolemia

    approved small molecule terminated

    1 trial
  10. Praluent (Alirocumab)

    Regeneron UK Limited

    Hypercholesterolemia

    approved small molecule completed

    1 trial
  11. Provase

    Chongqing Precision Biotech Co., Ltd

    Pruritus

    approved other completed

    1 trial
  12. ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, Placebo to KJX839 (Inclisiran sodium) 0 mg/1.5 mL solution for injection in pre-filled syringe, INCLISIRAN

    Novartis Pharmaceuticals

    Hypercholesterolemia

    approved small molecule active

    1 trial
  13. Recombinant human growth hormone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Achondroplasia

    approved small molecule active

    1 trial
  14. Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules)

    United Therapeutics Europe Ltd

    Diarrhea

    approved mab active

    1 trial
  15. Rescue Intravitreal Aflibercept Injection

    Regeneron UK Limited

    Neovascular Polypoidal Choroidal Vasculopathy

    approved small molecule active

    1 trial
  16. Rosuvastatin and Ezetimibe morning or evening administration

    COLLEGIUM PHARMACEUTICAL, INC

    Hypercholesterolemia

    approved small molecule completed

    1 trial
  17. Salkera Emollient Foam

    Chongqing Precision Biotech Co., Ltd

    Keratosis Pilaris

    approved small molecule terminated

    1 trial
  18. Same form and composition of the drug, except for the active ingredient., BRONCHO VAXOM Adulti 7 mg capsule rigide

    Fondazione Telethon ETS

    Elderly patients with a positive history of at least two respiratory system infections in the year preceding enrollment and residents for at least 6 months in a Healthcare Residence.

    approved small molecule active

    1 trial
  19. Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

    Sanofi Pasteur

    Cholera

    approved mab completed

    1 trial
  20. Succinylcholine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    the Effect of Succinylcholine on Barrier Pressure

    approved small molecule completed

    1 trial
  21. TACHOSIL GROUP

    Takeda

    Lymphocele

    approved mab completed

    1 trial
  22. Test preparation:Methylcholine chloroacetate for inhalation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Asthma

    approved small molecule completed

    1 trial
  23. Test preparation:Methylcholine chloroacetate for inhalation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy People

    approved small molecule completed

    1 trial
  24. The placebo MDI is formulated as a suspension of spray-dried porous particles (consisting of 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC] and calcium chloride) in a hydrofluoroalkane propellant (HFA-134a). The placebo MDI uses the same excipients as active product but with absence of the active pharmaceutical ingredient (API)., Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation, suspension

    AstraZeneca AB

    Chronic Obstructive Pulmonary Disease

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources